Application Sponsors
| ANDA 213985 | XIAMEN LP PHARM CO | |
Marketing Status
| Prescription | 001 |
| Prescription | 002 |
| Prescription | 003 |
Application Products
| 001 | CAPSULE, EXTENDED RELEASE;ORAL | 7MG | 0 | MEMANTINE HYDROCHLORIDE | MEMANTINE HYDROCHLORIDE |
| 002 | CAPSULE, EXTENDED RELEASE;ORAL | 14MG | 0 | MEMANTINE HYDROCHLORIDE | MEMANTINE HYDROCHLORIDE |
| 003 | CAPSULE, EXTENDED RELEASE;ORAL | 28MG | 0 | MEMANTINE HYDROCHLORIDE | MEMANTINE HYDROCHLORIDE |
FDA Submissions
| UNKNOWN; | ORIG | 1 | AP | 2022-10-11 | STANDARD |
Submissions Property Types
TE Codes
| 001 | Prescription | AB |
| 002 | Prescription | AB |
| 003 | Prescription | AB |
CDER Filings
XIAMEN LP PHARM CO
cder:Array
(
[0] => Array
(
[ApplNo] => 213985
[companyName] => XIAMEN LP PHARM CO
[docInserts] => ["",""]
[products] => [{"drugName":"MEMANTINE HYDROCHLORIDE","activeIngredients":"MEMANTINE HYDROCHLORIDE","strength":"7MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"MEMANTINE HYDROCHLORIDE","activeIngredients":"MEMANTINE HYDROCHLORIDE","strength":"14MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"MEMANTINE HYDROCHLORIDE","activeIngredients":"MEMANTINE HYDROCHLORIDE","strength":"28MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"10\/11\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-10-11
)
)